rs3218076
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001238.4(CCNE1):c.*586T>G variant causes a downstream gene change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.331 in 196,756 control chromosomes in the GnomAD database, including 12,270 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.35 ( 10234 hom., cov: 30)
Exomes 𝑓: 0.26 ( 2036 hom. )
Consequence
CCNE1
NM_001238.4 downstream_gene
NM_001238.4 downstream_gene
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.0450
Publications
15 publications found
Genes affected
CCNE1 (HGNC:1589): (cyclin E1) The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance through the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK2, whose activity is required for cell cycle G1/S transition. This protein accumulates at the G1-S phase boundary and is degraded as cells progress through S phase. Overexpression of this gene has been observed in many tumors, which results in chromosome instability, and thus may contribute to tumorigenesis. This protein was found to associate with, and be involved in, the phosphorylation of NPAT protein (nuclear protein mapped to the ATM locus), which participates in cell-cycle regulated histone gene expression and plays a critical role in promoting cell-cycle progression in the absence of pRB. [provided by RefSeq, Apr 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.484 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CCNE1 | ENST00000262643.8 | c.*586T>G | downstream_gene_variant | 1 | NM_001238.4 | ENSP00000262643.3 | ||||
| CCNE1 | ENST00000444983.6 | c.*586T>G | downstream_gene_variant | 1 | ENSP00000410179.2 | |||||
| CCNE1 | ENST00000357943.9 | c.*586T>G | downstream_gene_variant | 1 | ENSP00000350625.6 | |||||
| CCNE1 | ENST00000574121.1 | n.*83T>G | downstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.353 AC: 53319AN: 151012Hom.: 10203 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
53319
AN:
151012
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.257 AC: 11715AN: 45624Hom.: 2036 AF XY: 0.256 AC XY: 5435AN XY: 21232 show subpopulations
GnomAD4 exome
AF:
AC:
11715
AN:
45624
Hom.:
AF XY:
AC XY:
5435
AN XY:
21232
show subpopulations
African (AFR)
AF:
AC:
658
AN:
1680
American (AMR)
AF:
AC:
353
AN:
1116
Ashkenazi Jewish (ASJ)
AF:
AC:
587
AN:
2936
East Asian (EAS)
AF:
AC:
3416
AN:
7032
South Asian (SAS)
AF:
AC:
147
AN:
360
European-Finnish (FIN)
AF:
AC:
116
AN:
384
Middle Eastern (MID)
AF:
AC:
41
AN:
306
European-Non Finnish (NFE)
AF:
AC:
5461
AN:
28064
Other (OTH)
AF:
AC:
936
AN:
3746
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
354
709
1063
1418
1772
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
56
112
168
224
280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.353 AC: 53391AN: 151132Hom.: 10234 Cov.: 30 AF XY: 0.358 AC XY: 26446AN XY: 73802 show subpopulations
GnomAD4 genome
AF:
AC:
53391
AN:
151132
Hom.:
Cov.:
30
AF XY:
AC XY:
26446
AN XY:
73802
show subpopulations
African (AFR)
AF:
AC:
20108
AN:
41062
American (AMR)
AF:
AC:
6010
AN:
15112
Ashkenazi Jewish (ASJ)
AF:
AC:
863
AN:
3464
East Asian (EAS)
AF:
AC:
2465
AN:
5140
South Asian (SAS)
AF:
AC:
2172
AN:
4792
European-Finnish (FIN)
AF:
AC:
2857
AN:
10348
Middle Eastern (MID)
AF:
AC:
62
AN:
294
European-Non Finnish (NFE)
AF:
AC:
17795
AN:
67910
Other (OTH)
AF:
AC:
682
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1649
3297
4946
6594
8243
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
516
1032
1548
2064
2580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1895
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.